The Effects of Ultrasound-guided PRF Versus DN in Myofascial Pain Patients
NCT ID: NCT06851000
Last Updated: 2025-03-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
68 participants
INTERVENTIONAL
2025-02-25
2026-03-25
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pulsed Radiofrequency vs Dry Needling in Myofascial Pain
NCT05637047
Efficacy of Peripheral Magnetic Stimulation Compare to Dry Needling in Myofascial Pain Syndrome
NCT05320601
Evaluation of the Efficacy and Neurological Effects of Dry Needling in the Treatment of Myofascial Pain Syndrome
NCT02179320
Comparison of Focused ESWT by Frequency for Patients With Myofascial Pain Syndrome
NCT04998630
Analgesic Effects of Ultrasound-guided Dry-Needling Therapy for Neck and Head Pain
NCT03869710
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
PRF-PRF
ultrasound-guided pulsed radiofrequency
Medication: 0-3months; Pulsed radiofrequency: week 2, 6, 10;
DN-PRF
ultrasound-guided dry needling
Medication: 0-3 months; Dry needling: week 2; Pulsed radiofrequency: week 6, 10;
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ultrasound-guided pulsed radiofrequency
Medication: 0-3months; Pulsed radiofrequency: week 2, 6, 10;
ultrasound-guided dry needling
Medication: 0-3 months; Dry needling: week 2; Pulsed radiofrequency: week 6, 10;
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Myofascial pain diagnosed according to the "Simons and Travell" criteria.
* Able to complete treatment and follow-up.
* Signed inform consent form.
Exclusion Criteria
* Severe systemic disease, e.g. malignant tumor; severe hepatic, renal, or coagulation disorder; etc.
* Pregnancy, needle phobia, unable to cooperate.
* Concurrently receiving pain treatment in other institutions.
18 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Peking Union Medical College Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Cui Xulei
Principal investigator
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PRF-DN
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.